Tesamorelin: The Only GHRH Analog With FDA Approval — and What That Actually Means for Research
It went through the full clinical trial process. It got approved. It’s been prescribed for years. And it still might be the most underappreciated compound in the GH secretagogue research space. In a peptide landscape full of compounds that have never seen the inside of a Phase III trial, tesamorelin stands apart. It has full […]